MedTrace Logo

Mind-body Medicine for Patients With Malignant Hematological Diseases

NCT03735992 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 94

Last updated 2026-04-15

No results posted yet for this study

Summary

This randomized controlled trial aims to investigate the effectiveness of a mind-body group program as a supprtivemanagement strategy for fatigue in patients with malignant hematological diseases.

Conditions

  • Hematologic Neoplasms

Interventions

BEHAVIORAL

Mind-body medicine group program

The group program is mainly based on MBSR. It further integrates elements of the mind-body medicine cancer program of the Benson-Henry Mind/Body Medical Institute at Harvard Medical School which is rooted in psychoneuroendocrinology and focuses on relaxation techniques, exercise, cognitive restructuring, diet, and social support. In addition, naturopathic methods of selfregulation and self-care are incorporated.

Sponsors & Collaborators

  • Robert Bosch Medical Center

    collaborator OTHER

  • Universität Duisburg-Essen

    lead OTHER

Principal Investigators

  • Gustav Dobos, Prof. MD · Center for Integrative Medicine and Health, University Hospital Essen, University of Duisburg-Essen

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-06
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03735992 on ClinicalTrials.gov